[ad_1]
Truvada, a preventive anti-HIV treatment manufactured by the American Gilead, is insufficiently used in France by homobaduals and people born in countries of sub-Saharan Africa, which constitute the majority of people infected each year in France, According to a report of Igas made public on Monday.
This means of prevention called pre-exposure prophylaxis (Prep) is the subject of a poster campaign by the badociation Aides.
This mission report Inspectors Gilles Duhamel and Aquilino Morelle of the Inspectorate General of Social Affairs (Igas), revealed by the daily newspaper Le Monde, is pointing out a length of time for the Truvada "Temporarily Long" Temporary Use Recommendation (RTU).
A delay that resulted in "contaminations that could have been avoided" that would be "about 350 taking into account a gradual increase in load of the device," said the Igas in a statement.
"Conversely, the provision of Truvada" via the temporary recommendation (RTU) "allowed France to earn 7.5 months compared to the European marketing authorization (AMM) and avoid between 600 and 1,500 HIV infections "adds Igas.
Igas," despite the highly documented and detailed nature of this report, "deems" regrettable the virulent tone sometimes used by his as well as excessive language ", while remaining" strongly committed to the transparency of its work and the independence of its inspectors ".
The implementation of the temporary recommendation of the preventive Truvada" was proceeded satisfactorily ". This temporary recommendation ended on 1 March 2017, with the extension of the marketing authorization for this product for prevention.
The inspectors nevertheless point out "a double inequality in access to treatment: territorial inequality (for the benefit of metropolitan urban areas) and insufficient recourse among men who have bad with men (MSM) and those born in heavily affected countries, mainly in Sub-Saharan Africa, which constitute the vast majority of the some 6.000 new contaminations each year
– "Accumulated delay" –
"Particular attention must be paid to the extremely worrying situation in Guyana", they add.
The implementation of this measure of PREP intervened three years after the badociation Aides had seized the Agence du Médicale (ANSM), and three and a half years after the authorization of this trait. Preventive action in the United States took place on 16 July 2012.
The inspectors set out scenarios evoking the number of contaminations avoided thanks to France's advance in Europe or on the contrary "several hundred" or several thousand that could have been avoided if the decision process had been faster.
They thus evoke "a number of contaminations consecutive to the accumulated delay" being then "between 1.666 and 4.000". An estimate based on a hypothesis – of which they have "not had the possibility to verify the bases", they specify – of the general direction of the health which estimated that "the number of contaminations avoided (thanks to the Prep) would be potentially from 1,000 to 2,400 per year. "
" France was the first country in Europe to effectively allow, from January 2016, the use of Truvada as a preventive measure, "said AFP. Dr. Dominique Martin, Director General of the Agence du médicament
"This (last) evaluation of Igas is an absurd paradox compared to reality, since we intervened before other European countries", s
In fact, "the Prep is still little used – by only 6% of the people concerned, according to the data we have," he says noting that the estimates of the DGS of 2015 are "better than today".
[ad_2]
Source link
